Purchase Order 75N93023P00990

Genscript USA Inc. was awarded a $28,860.96 purchase order contract by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to provide research services and supplies in Piscataway, New Jersey. The firm-fixed price contract runs from July 11, 2023 through January 31, 2024 to support NIH/NIAID's efforts to study and address public health issues related to allergies and infectious diseases. No subcontractors or set aside...

The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $11,453 purchase order to Genscript USA Inc. to provide custom peptide synthesis services in support of H1/HA programs. The firm fixed price contract runs from September 18, 2023 through December 29, 2023 and will be performed in Piscataway, New Jersey. Genscript will synthesize peptides to advance NIH's research on influenza viruses under the contract....

Genscript USA Inc. has been awarded a $24,705 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide services for creating customized monoclonal antibodies and plasmids in support of the agency's biomedical research efforts. As the prime contractor, Genscript will leverage its expertise in gene synthesis and monoclonal antibody development to deliver the requested biological products and services. This contract...

This contract was awarded by the National Institutes of Health (NIH) National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The $5,353.40 firm fixed price delivery order is for peptide services and was completed on September 9, 2015. The contract has no set-aside designation. Genscript is a supplier of various products and services to federal agencies, including gene synthesis, gene editing, custom protein and antibody production, and...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $13,459 purchase order to Genscript USA Inc. to provide custom subcloning and antibody sequencing services in support of the agency's biomedical research efforts. Work will be performed by Genscript in Piscataway, New Jersey over a three-month period concluding in early October 2023. The firm fixed price contract was awarded under an unidentified agency-wide...

This firm fixed price delivery order awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Genscript USA Inc., a for-profit biotechnology company, has a potential value of $8,163.25. The award is for peptide services and does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, protein production, and other molecular biology services to various federal agencies, including the NIH, CDC, FDA, and...

Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $14,779.98 firm fixed price purchase order to Genscript USA Inc. for transient expression, purification and plasmid preparation services in support of AMBIS program activities. Performance will take place in Piscataway, New Jersey over a two month period concluding on September 30, 2023. The contract calls for Genscript to deliver requested biomanufacturing...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $250,000 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. The order is for gene production and protein expression services to support the agency's research efforts. Services include gene synthesis, cloning, plasmid preparation, and protein expression and purification. The sole source award was negotiated under the authority of 41 U.S.C. 1901(a)(1) based on...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $17,709 purchase order to Genscript USA Inc. to provide custom gene synthesis and expression services in support of its research efforts. The firm fixed price contract has a period of performance from September 18, 2023 through December 31, 2023 and will be carried out by Genscript at its facility located in Bethesda, Maryland. No major subcontractors or set aside designations were identified....